Trial NCT01121757

View at ClinicalTrials.gov 
Org. Study IDs: Pro00019069

Last trial update was posted on 2016-09-12

MeSH Interventions

Azacitidine Lenalidomide

MeSH Conditions

Lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Follicular

Other Conditions

Follicular Lymphoma Marginal Zone Lymphoma

Stopping Reasons

The study closed temporarily in February 2012 pending analysis of samples collected. In October, 2012, Celgene requested closure of the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID